Submission Details
| 510(k) Number | K071346 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 14, 2007 |
| Decision Date | September 24, 2007 |
| Days to Decision | 133 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Statement |
K071346 is an FDA 510(k) clearance for the IMMULISA INTRINSIC FACTOR ANTIBODY ELISA, a Radioassay, Intrinsic Factor Blocking Antibody (Class II — Special Controls, product code LIG), submitted by Immco Diagnostics, Inc. (Buffalo, US). The FDA issued a Cleared decision on September 24, 2007, 133 days after receiving the submission on May 14, 2007. This device falls under the Immunology review panel. Regulated under 21 CFR 862.1810.
| 510(k) Number | K071346 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 14, 2007 |
| Decision Date | September 24, 2007 |
| Days to Decision | 133 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Statement |
| Product Code | LIG — Radioassay, Intrinsic Factor Blocking Antibody |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1810 |